Astrazeneca plc ADR (NASDAQ:AZN) currently has a daily average trading volume of 5.59M but it saw 5464121 shares traded in last market. With a market cap of 234.36B USD, the company’s current market price of $75.57 came rising about 1.79 while comparing to the previous closing price of $74.24. In past 52 weeks, the stock remained buoying in the range of price level as high as $87.68 and as low as $62.75. In the recent trading on the day, stock has struck highest price mark of $74.69 while lowest mark touched by it was $75.78.
Taking a look at 20-day trading activity of Astrazeneca plc ADR (AZN) gives us an average price of $75.47, while its current price level is -13.81% below from 52-week high level whereas it is 20.43% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $71.23 while that of 200 days or SMA-200 reads an average of $74.91. A closer look into the stock’s movement over the week reveals that its volatility is standing at 1.56% during that period while stretching the period over a month that decreases to 1.40%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 56.04 which implies that the stock is in neutral territory.
Over the week, AZN’s stock price is moving -3.07% down while it is 4.00% when we observe its performance for the past one month. Year-to-date it is 15.34% up and over the past year, the stock is showing an upside performance of 13.64%.
The company is expected to be releasing its next quarterly report on 2025-Feb-05, for which analysts forecasted an EPS of 1.1 while estimate for next year EPS is 4.42. In next quarter, company is expected to be making quarterly sales of $14.02B as analysts are expecting the sales for current fiscal year at $57.35B and seeing the company making $60.87B in sales next year. Moreover, analysts are in estimates of $13.74B for current-quarter revenue.
Currently, Astrazeneca plc ADR’s total number of outstanding shares is 3.10B with 0.00% of that held by the insiders while 17.50% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 10.28% and return on equity (ROE) at 17.60%. It has a price to earnings ratio (P/E ratio) of 33.53 while having a 14.94 of forward P/E ratio. Stock’s beta reads 0.49. Stock has a price to book (P/B) ratio of 5.75 while price to sale or P/S ratio amounts to 4.33. Its return on asset (ROA) is 6.86% on average.
